Vanda Pharmaceuticals Stock Short Ratio
| VNDA Stock | USD 4.58 0.05 1.10% |
Vanda Pharmaceuticals fundamentals help investors to digest information that contributes to Vanda Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Vanda Stock. The fundamental analysis module provides a way to measure Vanda Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vanda Pharmaceuticals stock.
Vanda |
Vanda Pharmaceuticals Company Short Ratio Analysis
Vanda Pharmaceuticals' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Vanda Pharmaceuticals Short Ratio | 5.23 X |
Most of Vanda Pharmaceuticals' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vanda Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Vanda Pharmaceuticals has a Short Ratio of 5.23 times. This is 34.1% higher than that of the Biotechnology sector and 29.42% lower than that of the Health Care industry. The short ratio for all United States stocks is 30.75% lower than that of the firm.
Vanda Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vanda Pharmaceuticals' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vanda Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Vanda Pharmaceuticals by comparing valuation metrics of similar companies.Vanda Pharmaceuticals is currently under evaluation in short ratio category among its peers.
Vanda Fundamentals
| Return On Equity | -0.0302 | ||||
| Return On Asset | -0.0364 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.23) % | ||||
| Current Valuation | (101.27 M) | ||||
| Shares Outstanding | 58.31 M | ||||
| Shares Owned By Insiders | 3.15 % | ||||
| Shares Owned By Institutions | 76.98 % | ||||
| Number Of Shares Shorted | 3.29 M | ||||
| Price To Earning | 24.83 X | ||||
| Price To Book | 0.49 X | ||||
| Price To Sales | 1.40 X | ||||
| Revenue | 192.64 M | ||||
| Gross Profit | 230.1 M | ||||
| EBITDA | (13.95 M) | ||||
| Net Income | 2.51 M | ||||
| Cash And Equivalents | 440.86 M | ||||
| Cash Per Share | 7.79 X | ||||
| Total Debt | 9.4 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 5.62 X | ||||
| Book Value Per Share | 9.28 X | ||||
| Cash Flow From Operations | 12.8 M | ||||
| Short Ratio | 5.23 X | ||||
| Earnings Per Share | (0.19) X | ||||
| Price To Earnings To Growth | (2.42) X | ||||
| Target Price | 10.43 | ||||
| Number Of Employees | 203 | ||||
| Beta | 0.77 | ||||
| Market Capitalization | 314.86 M | ||||
| Total Asset | 648.44 M | ||||
| Retained Earnings | (155.39 M) | ||||
| Working Capital | 345.25 M | ||||
| Current Asset | 166.55 M | ||||
| Current Liabilities | 51.32 M | ||||
| Net Asset | 648.44 M |
About Vanda Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vanda Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vanda Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vanda Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vanda Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vanda Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vanda Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vanda Pharmaceuticals Stock:Check out Vanda Pharmaceuticals Piotroski F Score and Vanda Pharmaceuticals Altman Z Score analysis. For information on how to trade Vanda Stock refer to our How to Trade Vanda Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vanda Pharmaceuticals. If investors know Vanda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vanda Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vanda Pharmaceuticals is measured differently than its book value, which is the value of Vanda that is recorded on the company's balance sheet. Investors also form their own opinion of Vanda Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vanda Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vanda Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vanda Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vanda Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vanda Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vanda Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.